Akebia secures up to $140 million term loan from Symbiotic Capital, repays BlackRock-linked debtNov 16FinancingAkebia Therapeutics
Akebia reports Q3 2026 results as Vafseo patient count grows and VOICE, VOCAL data landNov 5Quarterly updateAkebia Therapeuticsvadadustat
Akebia Therapeutics receives Nasdaq notice over low stock priceOct 23Exchange listingAkebia Therapeutics
Akebia reports Q2 2026 results, VOICE interim data, and new ebribafusp trialAug 5Quarterly updateAkebia Therapeuticsvadadustat
Akebia and USRC halt VOICE trial early after Vafseo beats ESA on safetyJun 30Clinical readoutAkebia Therapeuticsvadadustat